Skip to content


Frontline Excellence: Life Sciences Manufacturing Forecasts for 2024

As we head into 2024, choosing the right systems and processes to increase the productivity of your frontline operations is more critical than ever.

The life sciences manufacturing environment is evolving rapidly — with new and evolving technologies constantly entering the scene. These emergent solutions are transforming processes across a variety of use cases, from audit preparation to incident investigation.

Of course, with these shifts comes associated regulatory implications. The FDA and EMA have been introducing best practices and guidance around using the latest technology — and will continue to do so in the coming months.

Digital transformation is no longer optional in the life sciences sector, and agility is key to your organization’s ability to capitalize on the latest shifts and remain competitive.

Join us for a deep-dive discussion between Gilad Langer, Industry Practice Lead at Tulip, and Michelle Vuolo, Quality Practice Lead at Tulip, on the current state of frontline operations — and what to expect in 2024.

In this webinar, they’ll:

  • Assess the predictions we had made for 2023 — and whether or not they came to fruition

  • Outline some of the current life sciences industry shifts and frontline operations challenges

  • Highlight our predictions for 2024 — providing tips on how you should adapt your strategy accordingly


  • Headshot of Michelle Vuolo

    Michelle Vuolo

    Head of Quality, Tulip

  • Head of Customer Services and Life Sciences Practice Lead, Tulip

    Gilad Langer

    Industry Practice Lead, Tulip